Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-64.89	4.14	11.78
Graham Fair Price	38.22	15764.87	11405.24
PEG	-79.02	0.03	-0.16
Price/Book	2.66	0.28	0.27
Price/Cash Flow	30.71	16.48	12.61
Prices/Earnings	-44.15	2.95	5.28
Price/Sales	7.70	0.35	0.32
Price/FCF	30.71	16.48	12.61
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.15	0.34	0.32
Operating Margin	17.52	0.08	0.07
ROA	82.58	< 0.005	< 0.005
ROE	0.01	0.02	83.82
ROIC	0.02	0.03	6.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	-0.06	17.23
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.05	0.14	171.83
EPS QOQ	-0.33	0.87	166.22
FCF QOQ	2.55	-0.20	-92.18
Revenue QOQ	0.04	-0.03	-27.34
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.07	38.91	10.96
Days Sales Outstanding (DSO)	40.49	42.22	4.25
Inventory Turnover	2.57	2.31	-9.88
Debt/Capitalization	0.49	0.50	2.39
Quick Ratio	0.42	0.52	23.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21080.24	21491.16	1.95
Cash	2305.06	3947.76	71.27
Capex	-1654.96	-729.79	55.90
Free Cash Flow	459.11	367.62	-19.93
Revenue	17850.94	17348.26	-2.82
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.62	0.74	19.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.99	3.11	-65.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating